Treatment of the idiopathic inflammatory myopathies

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F18%3A10385382" target="_blank" >RIV/00216208:11110/18:10385382 - isvavai.cz</a>
Alternative codes found
RIV/00023728:_____/18:N0000089
Result on the web
<a href="https://catalog.loc.gov/vwebv/holdingsInfo?searchId=2393&recCount=25&recPointer=16&bibId=19988562" target="_blank" >https://catalog.loc.gov/vwebv/holdingsInfo?searchId=2393&recCount=25&recPointer=16&bibId=19988562</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Treatment of the idiopathic inflammatory myopathies
Original language description
Treatment of idiopathic inflammatory myopathies (IIMs) is challenging, because these disorders are rare with heterogeneous clinical manifestations and incompletely understood aetiopathogenesis. There have been only a few randomized controlled clinical trials (RCT), often involving small numbers of patients; therefore treatment strategies are mostly empirical. Management of IIMs should be multidisciplinary and tailored to disease activity and clinical phenotype of a given patient. The goal is to improve muscle strength and to supress extramuscular manifestations of the disease, while minimizing the risk of complications. Pharmacotherapy is the cornerstone of disease management, with the exception of sIBM, which is typically treatment resistant. Exercise is recommended from early disease stages. Side effects of treatment should be carefully monitored.
Czech name
—
Czech description
—

Publication year
2018
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)